Physician profile
Alejandro Rocha
NPI 1801358338
$720.06
in general payments reported to CMS, 2019-2025
10 companies · $13.51 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $310 · 2023: $204 · 2024: $193 · 2025: $13.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $410.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $206.49 | 2022-2024 | Ozempic, Rybelsus |
| W. L. Gore & Associates, INC. | $185.39 | 2023 | Viabahn Endoprosthesis With Propaten Bioactive Surface |
| Medtronic, INC. | $143.40 | 2022 | |
| Exact Sciences Corporation | $48.96 | 2024-2025 | Cologuard Collection Kit |
| Philips North America LLC | $35.52 | 2024 | (Ck7) Extended Holter |
| Vanda Pharmaceuticals INC. | $30.14 | 2024 | Fanapt |
| Astrazeneca Pharmaceuticals Lp | $18.79 | 2024 | Airsupra |
| Glaxosmithkline, LLC. | $18.56 | 2023 | Trelegy Ellipta |
| Lilly USA, LLC | $17.93 | 2024 | Mounjaro, Zepbound |
| Abbvie INC. | $14.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandro Rocha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.